The Incoherence Of |
s: The Incoherence Of Naming In The Pharmaceutical IndustryIt would be easy if all drugs fit into categories named after the seven dwarves (Sleepy, Sneezy, Dopey, Happy���etc). Unfortunately, the naming of new drugs is well short of a fairytale process. Drugs, regardless of prescription or over-the-counter status, lack a coherent brand-naming standard. The seemingly random production of brand name drugs not only prevents consumer (and physician) efficacy but also obstructs many helpful drugs from the view of the target market.For example, have you ever heard of Callisto, Ridomil, Actara, or Quadris Perhaps you have taken one of those for a headache or for chronic back pain. We hope not because those are actually brand names of crop protection chemicals. What is the difference between a name like Callisto or Actara as opposed to Cialis or Allegra They are created by marketing firm ABC for product XYZ. There is no differentiation. There is no brand. In the pharmaceutical industry, th}, responseDetails: null, responseStatcomposi
|
|
The Incoherence Of |
|
